We are live on ! Find out more
SBWIC

Schaper Benz & Wise Investment Counsel Portfolio holdings

AUM $1.5B
1-Year Est. Return 31.02%
This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+31.02%
3 Year Est. Return
+83.38%
5 Year Est. Return
+96.2%
10 Year Est. Return
+357.25%
AUM
$461M
AUM Growth
+$11.9M
Cap. Flow
-$518K
Cap. Flow %
-0.11%
Top 10 Hldgs %
30.59%
Holding
92
New
–
Increased
29
Reduced
43
Closed
1

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.49M
2
ABT icon
Abbott
ABT
+$1.08M
3
APA icon
APA Corp
APA
+$1.05M
4
VFC icon
VF Corp
VFC
+$447K
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$351K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.13M
2
WU icon
Western Union
WU
+$1.23M
3
ABBV icon
AbbVie
ABBV
+$545K
4
SLM icon
SLM Corp
SLM
+$263K
5
WBA
Walgreens Boots Alliance
WBA
+$259K

Sector Composition

Rank Sector Weight
1 Technology 18.93%
2 Financials 18.53%
3 Healthcare 18%
4 Consumer Staples 7.2%
5 Energy 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDXX icon
51
Idexx Laboratories
IDXX
$46.2B
$1.86M 0.4%
30,700
– –
PX
52
DELISTED
Praxair Inc
PX
$1.78M 0.39%
13,625
+2,275
+20% +$295K
BRK.A icon
53
Berkshire Hathaway Class A
BRK.A
$1.11T
$1.69M 0.37%
9
+2
+29% +$351K
TSS
54
DELISTED
Total System Services, Inc.
TSS
$1.64M 0.36%
53,800
-3,365
-6% -$103K
V icon
55
Visa
V
$677B
$1.62M 0.35%
30,080
+1,400
+5% +$77.8K
TEVA icon
56
Teva Pharmaceuticals
TEVA
$42.5B
$1.59M 0.34%
30,030
-67,695
-69% -$3.13M
SLB icon
57
SLB Ltd
SLB
$79.7B
$1.51M 0.33%
15,514
-200
-1% -$18.1K
INTU icon
58
Intuit
INTU
$92B
$1.5M 0.32%
19,256
– –
ECL icon
59
Ecolab
ECL
$79.8B
$1.5M 0.32%
13,840
+3,050
+28% +$319K
GE icon
60
GE Aerospace
GE
$382B
$1.42M 0.31%
11,430
+2,347
+26% +$290K
APA icon
61
APA Corp
APA
$14.2B
$1.41M 0.31%
16,965
+12,805
+308% +$1.05M
ASB icon
62
Associated Banc-Corp
ASB
$6.02B
$1.38M 0.3%
76,213
-8,000
-9% -$136K
PG icon
63
Procter & Gamble
PG
$338B
$1.31M 0.28%
16,225
– –
ABBV icon
64
AbbVie
ABBV
$442B
$1.28M 0.28%
24,964
-10,782
-30% -$545K
SLM icon
65
SLM Corp
SLM
$5.11B
$1.05M 0.23%
120,412
-30,078
-20% -$263K
CHS
66
DELISTED
Chicos FAS, Inc.
CHS
$995K 0.22%
62,045
– –
PEP icon
67
PepsiCo
PEP
$189B
$945K 0.21%
11,315
– –
VFC icon
68
VF Corp
VFC
$5.81B
$781K 0.17%
13,397
+7,938
+145% +$447K
IBM icon
69
IBM
IBM
$225B
$659K 0.14%
3,579
-6
-0.2% -$1.06K
BIDU icon
70
Baidu
BIDU
$35.9B
$645K 0.14%
4,235
+150
+4% +$25.1K
MMM icon
71
3M
MMM
$94.4B
$610K 0.13%
5,380
-1,088
-17% -$121K
CVX icon
72
Chevron
CVX
$386B
$588K 0.13%
4,941
– –
CMP icon
73
Compass Minerals
CMP
$1.13B
$582K 0.13%
7,050
– –
WTS icon
74
Watts Water Technologies
WTS
$12.8B
$571K 0.12%
9,725
– –
TPR icon
75
Tapestry
TPR
$32.4B
$422K 0.09%
8,505
-4,950
-37% -$246K
1 2
3
4

Similar funds

SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return

Schaper Benz & Wise Investment Counsel's Q1 2014 Portfolio in Review

As of Q1 2014, Schaper Benz & Wise Investment Counsel held 92 positions worth $461M, up 2.7% from $449M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 1.1%. Schaper Benz & Wise Investment Counsel opened no new positions and exited 1, leaving the 92-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Schaper Benz & Wise Investment Counsel added most to Berkshire Hathaway Class B in Q1 2014, an estimated $2.49M increase.
  • Schaper Benz & Wise Investment Counsel's biggest Q1 2014 reduction was Teva Pharmaceuticals, cutting an estimated $3.13M.
  • Schaper Benz & Wise Investment Counsel fully exited B&G Foods in Q1 2014, selling an estimated $248K.
  • Schaper Benz & Wise Investment Counsel's ten largest holdings make up 31% of its $461M portfolio in Q1 2014.
  • Schaper Benz & Wise Investment Counsel opened 0 new positions and closed 1 in Q1 2014.
  • Schaper Benz & Wise Investment Counsel's portfolio value rose 2.7% quarter-over-quarter to $461M.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q1 2014, filed 2 May 2014.